Boston Scientific To Pay Cordis $716M In Stent War
Following more than a decade of litigation, Boston Scientific Corp. has agreed to fork over a whopping $716 million to Johnson & Johnson unit Cordis Corp. to settle more than a...To view the full article, register now.
Already a subscriber? Click here to view full article